(AGENPARL) – WEST LAFAYETTE (U.S.) gio 20 aprile 2023 Purdue Ventures, which manages three funds to support Purdue University-connected startups, has invested $250,000 in TRIO Pharmaceuticals Inc., a cancer immunotherapeutics startup founded by a Purdue University biophysics and structural biology alumnus. The company’s antibody-based therapeutics strengthens the body’s defense, the immune system, to eradicate cancer.
Fonte/Source: http://www.purdue.edu/newsroom/releases/2023/Q2/purdue-ventures-invests-in-antibody-based-cancer-therapeutics-company.html